Diagnosis, Management and Modeling of Neurodevelopmental Disorders

<p>I. Introductory Chapters: Setting the Scene for the Neuroscience of Development<br>1. The brain and its structures: An overview<br>2. Neural tube defects: Embryonic origin, clinical features and cell survival equilibrium impact<br>3. Chemical substances affecting neurodevelopment<br>4. High-risk babies and Neurodevelopmental outcome<br>5. Genomic Imprinting and neurodevelopment<br>6. Insights from model systems: Alcohol, neurodevelopment and zebrafish<br>7. Early life nutrition and brain development: Maternal iodine nutrition and neurodevelopment<br>8. Endocrine Aspects of Development. Thyroid hormone actions in neurological processes during brain development</p> <p>II. Impairments and Diseases<br>9. Pediatric brain tumors<br>10. Neurofibromatosis Type 1: From cellular phenotypes to human brain function<br>11. The role and development of neural crest cells<br>12. Spina Bifida: A Biopsychosocial Perspective<br>13. Diabetic ketoacidosis and neurodevelopment<br>14. Four-dimensional features of fetal brain: Applications to diabetes<br>15. Prenatally exposed to nicotine and neurodevelopment<br>16. Maternal methamphetamine and impact on the brain<br>17. Alcohol, cannabis and brain development<br>18. The Environmental Pollutant Trichloroethylene Disrupts Key Neural Pathways During Brain Development<br>19. Developmental neurotoxicity of the herbicide atrazine<br>20. Neurodevelopmental delays and in utero hyperemesis gravidarum<br>21. Neurodevelopment and Infantile Epileptic Encephalopathy-9 (EIEE9)<br>22. Neurodevelopment in Turner syndrome<br>23. Very preterm children and the impact on neurodevelopmental outcomes<br>24. Linking congenital heart disease and brain functional connectivity in newborns<br>25. Brain Growth in Congenital Heart Disease from Prenatal Environment to Adulthood<br>26. Linking dopamine, amphetamine and neurodevelopment<br>27. Developmental coordination disorder</p> <p>III. Biomarkers, Screening, Methods and Diagnosis<br>28. Neurodevelopment and the The Ages and Stages Questionnaire, third edition (ASQ-3)<br>29. Screening for Attention Deficit Hyperactivity Disorder in children<br>30. The Mini-Mental State Pediatric Examination screening tool: Italian perspectives<br>31. Predictors of neurodevelopment in preterm infants: From the neonatal intensive care unit into adulthood <br>32. The antenatal fetal neurodevelopmental test: Uses and applications</p> <p>IV: Management and Treatments<br>33. Pain, evaluation and management in neurodevelopmental conditions<br>34. Use of levetiracetam: Features and applications to neonatal seizures<br>35. Quetiapine treatment in paediatric scenarios<br>36. Treatments with cannabinoids and brain development<br>37. Pediatric dystonia and deep brain stimulation<br>38. Use of repetitive transcranial magnetic stimulation in neurodevelopment: A narrative review<br>39. Cognitive behavioral therapy in children with anxiety disorders<br>40. Cognitive behavioral therapy for anxiety in children with autism spectrum disorder<br>41. Nutritional treatment in fetal alcohol spectrum disorder<br>42. Nurturing the Developing Brain to Reduce Neurological Delay<br>43. Normalizing perinatal neurological development via intervention</p> <p>V. Models and Modelling<br>44. Microplatforms as a Model for Neurological Conditions<br>45. Disease models in neurodevelopmental disorders<br>46. Endosulfan and impact on neurodevelopment: Modelling with zebrafish (Danio rerio)<br>47. Neurodevelopment of the zebrafish spinal serotonin system<br>48. Inbred mouse model of brain development and intestinal microbiota<br>49. The myelin mutant taiep rat as a model of developmental disorder<br>50. The MAM-E17 neurodevelopmental model of schizophrenia</p> <p>VI. Resources<br>51. Research and recommended resources in the neuroscience of development</p>